Related Experiment Videos
Summary
Children with cystic fibrosis (CF) exhibit a significantly higher risk of diabetes. This study reveals a specific defect in pancreatic beta cell function, characterized by delayed insulin release in response to glucose, impacting overall insulin secretion in CF patients.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Cystic Fibrosis Research
Context:
- Cystic Fibrosis (CF) patients have a tenfold higher risk of diabetes mellitus.
- Long-term pancreatic dysfunction in CF affects glucose metabolism.
- Understanding endocrine complications in pediatric CF is crucial.
Purpose:
- To investigate glucagon and insulin secretion in pediatric CF patients.
- To differentiate between alpha and beta cell function in CF-related diabetes.
- To characterize the pattern of insulin release in response to various stimuli.
Summary:
- CF patients demonstrate normal pancreatic alpha cell function and glucagon release.
- A specific defect in beta cell function was identified: delayed insulin release in response to glucose.
- Insulin output is diminished in response to both oral glucose and intravenous arginine, even with normal carbohydrate tolerance.
Impact:
- The findings reveal a distinct pattern of insulin secretion defect in CF, similar to chemical diabetes in adults.
- Reduced insulin secretion and potential peripheral insulin insensitivity contribute to hyperglycemia in CF.
- This research highlights the specific endocrine challenges in managing pediatric CF patients.